Myeloproliferative disorder

We’re all in this for good.

By sharing your stories and data, you will:
  • help each other live better and uncover the best ways to manage your health today
  • help researchers shorten the path to new treatments tomorrow

How much good can your data do? A whole lot, as co-founder Jamie Heywood explains in this video.

What is myeloproliferative disorder?

Myeloproliferative disorders are a group of blood cancers originating in the tissue inside the bone (bone marrow). The body produces too many abnormal red blood cells, white blood cells, or platelets that build up in the blood.

Common symptoms reported by people with myeloproliferative disorder

Common symptoms
How bad it is
What people are taking for it

Reports may be affected by other conditions and/or medication side effects. We ask about general symptoms (anxious mood, depressed mood, fatigue, pain, and stress) regardless of condition.
Last updated:

Treatments taken by people with myeloproliferative disorder

Treatment name(s)
Type
How many have tried
Tried for
Treatment name(s)

(Gleevec)
Type
Prescription Drug
How many have tried
1
Treatment name(s)

(Ultram)
Type
Prescription Drug
How many have tried
1
Tried for
pain (1)

Data from patients with myeloproliferative disorder, who reported starting treatments within the last 5 years.
Last updated:

Compare treatments taken by people with myeloproliferative disorder

Treatment name(s)
Perceived effectiveness
Side effects
Total evaluations
Tried for
Treatment name(s)

(Gleevec)
Perceived effectiveness
No evaluations
Side effects
nausea
Total evaluations
1
Treatment name(s)

(Ultram)
Perceived effectiveness
No evaluations
Side effects
No evaluations
Total evaluations
0
Tried for
pain (1)
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
  • Severe
  • Moderate
  • Mild
  • None

Data from patients with myeloproliferative disorder, who reported starting treatments within the last 5 years.
Last updated:

Who has myeloproliferative disorder on PatientsLikeMe?


Age
Age Proportion # of patients
<20 0
20s 0
30s 1
40s 7
50s 8
60s 9
70+ 4
Age at first symptom
Age at first symptom Proportion # of patients
0-19 years 0
20-29 years 1
30-39 years 6
40-49 years 2
50-59 years 3
60-69 years 3
70+ years 0

Distribution of sex

Sex
Sex Proportion # of patients
Male 3
Female 26

Diagnosis status
Diagnosis status Proportion # of patients
Diagnosed 18
Not Diagnosed 2

These charts show data from myeloproliferative disorder patients who have completed their condition history
Last updated: